Credit Suisse’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-20,292
| Closed | -$107K | – | 3630 |
|
|
2021
Q2 | $107K | Buy |
+20,292
| New | +$107K | ﹤0.01% | 3501 |
|
|
2020
Q4 | – | Sell |
-14,867
| Closed | -$49K | – | 3564 |
|
|
2020
Q3 | $49K | Buy |
+14,867
| New | +$49K | ﹤0.01% | 3194 |
|
|
2017
Q4 | – | Sell |
-11,473
| Closed | -$96K | – | 3661 |
|
|
2017
Q3 | $96K | Buy |
+11,473
| New | +$96K | ﹤0.01% | 3612 |
|
|
2016
Q3 | – | Sell |
-16,335
| Closed | -$111K | – | 3871 |
|
|
2016
Q2 | $111K | Buy |
+16,335
| New | +$111K | ﹤0.01% | 3730 |
|